<PubmedArticle>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">22595751</PMID>
<DateCompleted>
<Year>2012</Year>
<Month>11</Month>
<Day>20</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>12</Month>
<Day>01</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1090-2139</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>26</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2012</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Brain, behavior, and immunity</Title>
<ISOAbbreviation>Brain Behav. Immun.</ISOAbbreviation>
</Journal>
<ArticleTitle>A systematic review of the association between immunogenomic markers and cancer-related fatigue.</ArticleTitle>
<Pagination>
<MedlinePgn>830-48</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bbi.2012.05.004</ELocationID>
<Abstract>
<AbstractText>Fatigue, which is one of the most commonly reported symptoms in cancer, can negatively impact the functional status and the health-related quality of life of individuals. This paper systematically reviews 34 studies to determine patterns of associations between immunogenomic markers and levels of cancer-related fatigue (CRF). Findings from the longitudinal studies revealed that elevated fatigue symptoms especially of women with early stages of breast cancer were associated with high levels of neutrophil/monocyte, IL-1ra, and IL-6 during radiation therapy; high levels of CD4+, IL-1β, and IL-6 with stressing stimuli; high levels of IL-1β during chemotherapy; low NK cell levels after chemotherapy; and presence of homozygous IL-6 and TNF alleles. In the cross-sectional studies, associations between levels of fatigue and immune/inflammatory markers were not consistently found, especially when covariates such as BMI, ethnicity, menopausal status, and educational level were controlled in the statistical analyses. However, a number of genomic markers were observed to be elevated mostly in fatigued breast cancer survivors in the cross-sectional studies. Gaps in knowledge and recommendations for future research are discussed.</AbstractText>
<CopyrightInformation>Copyright © 2012 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Saligan</LastName>
<ForeName>L N</ForeName>
<Initials>LN</Initials>
<AffiliationInfo>
<Affiliation>National Institute of Nursing Research, National Institutes of Health, 9000 Rockville Pike, Building 10, Room 2-1339, Bethesda, MD 20892, USA. saliganl@mail.nih.gov</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kim</LastName>
<ForeName>H S</ForeName>
<Initials>HS</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>Z99 NR999999</GrantID>
<Acronym>NULL</Acronym>
<Agency>Intramural NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>ZIA NR000020-01</GrantID>
<Acronym>NULL</Acronym>
<Agency>Intramural NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D017418">Meta-Analysis</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
<PublicationType UI="D000078182">Systematic Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2012</Year>
<Month>05</Month>
<Day>14</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Brain Behav Immun</MedlineTA>
<NlmUniqueID>8800478</NlmUniqueID>
<ISSNLinking>0889-1591</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016207">Cytokines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D005819">Genetic Markers</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9007-41-4</RegistryNumber>
<NameOfSubstance UI="D002097">C-Reactive Protein</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015415">Biomarkers</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001943">Breast Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002097">C-Reactive Protein</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000032">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015496">CD4-Positive T-Lymphocytes</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003430">Cross-Sectional Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016207">Cytokines</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005221">Fatigue</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000276">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005819">Genetic Markers</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000276">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D023281">Genomics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008137">Longitudinal Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009369">Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000276">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017741">Survivors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2012</Year>
<Month>01</Month>
<Day>10</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2012</Year>
<Month>04</Month>
<Day>24</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2012</Year>
<Month>05</Month>
<Day>08</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2012</Year>
<Month>5</Month>
<Day>19</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2012</Year>
<Month>5</Month>
<Day>19</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2012</Year>
<Month>12</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">22595751</ArticleId>
<ArticleId IdType="pii">S0889-1591(12)00111-0</ArticleId>
<ArticleId IdType="doi">10.1016/j.bbi.2012.05.004</ArticleId>
<ArticleId IdType="pmc">PMC3398196</ArticleId>
<ArticleId IdType="mid">NIHMS382225</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>J Pain Symptom Manage. 2000 Jan;19(1):5-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10687321</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biol Res Nurs. 2009 Jul;11(1):27-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19419979</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oncologist. 2000;5(5):353-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11040270</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Oncol. 2001 Jul 15;19(14):3385-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11454886</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Psychosom Res. 2011 Sep;71(3):136-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21843747</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Oncol. 2011 Sep 10;29(26):3517-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21825266</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Behav Immun. 2011 Oct;25(7):1376-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21496483</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Pharmacol Exp Ther. 2012 Jan;340(1):152-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22005042</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Pain Symptom Manage. 2012 Feb;43(2):226-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21839608</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Nutr. 2012 Feb;31(1):85-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21855185</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Psychiatry Rep. 2012 Apr;14(2):129-37</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22198824</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Res. 2012 Mar 29;1446:144-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22342162</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Palliat Med. 2012 Apr;26(3):275-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21807751</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mediators Inflamm. 2012;2012:976241</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22481867</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Breast Cancer Res Treat. 2012 Jun;133(2):405-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21898113</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Radiat Oncol Biol Phys. 2001 Nov 1;51(3):691-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11597810</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Qual Health Res. 2002 May;12(5):655-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11993562</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>FEBS Lett. 2002 Apr 24;517(1-3):261-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12062449</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychosom Med. 2002 Jul-Aug;64(4):604-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12140350</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Br J Cancer. 2002 Jul 29;87(3):264-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12177792</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Oncol. 2003 Aug;23(2):269-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12851675</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Comp Neurol. 2004 Apr 19;472(1):113-29</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15024756</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Natl Cancer Inst. 2003 Aug 6;95(15):1165-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12902446</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biol Res Nurs. 2004 Jan;5(3):203-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14737921</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):160-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15093912</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Immunol Today. 1988 May;9(5):150-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3076770</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neuroimmunomodulation. 1995 May-Jun;2(3):161-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8646566</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Psychosom Res. 2004 Nov;57(5):435-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15581646</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biol Psychol. 2005 Apr;69(1):85-96</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15740827</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer. 2005 Aug 15;104(4):788-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15973668</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Treat Res. 2006;130:103-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16610705</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Cancer Res. 2006 May 1;12(9):2759-66</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16675568</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Metastasis Rev. 2006 Sep;25(3):387-408</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17043764</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Behav Immun. 2007 Mar;21(3):251-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17008048</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Behav Immun. 2009 Aug;23(6):868-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19362138</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Cancer Res. 2009 Sep 1;15(17):5534-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19706826</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pharmacogenomics J. 2009 Oct;9(5):333-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19546881</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Behav Immun. 2008 Nov;22(8):1197-200</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18617366</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunotoxicol. 2010 Mar;7(1):27-38</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20001788</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S272-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20061007</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cytokine Growth Factor Rev. 2010 Feb;21(1):3-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20005150</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Semin Immunol. 2010 Jun;22(3):113-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20403709</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Cancer. 2010 Jul;46(10):1848-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20400291</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer. 2010 Sep 1;116(17):4103-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20564140</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Natl Compr Canc Netw. 2010 Aug;8(8):904-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20870636</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Pain Symptom Manage. 2010 Oct;40(4):531-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20570482</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Behav Immun. 2011 Jan;25(1):147-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20854893</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int Rev Neurobiol. 2010;95:227-79</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21095465</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Cancer. 2011 Jul;47(11):1682-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21570824</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Expert Rev Pharmacoecon Outcomes Res. 2011 Aug;11(4):441-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21831025</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Cancer Res Clin Oncol. 2007 Jul;133(7):477-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17356858</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Pain Symptom Manage. 2008 Feb;35(2):153-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18082358</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Nurs. 2008 Mar-Apr;31(2):134-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18490890</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Invest. 2008 Sep;118(9):2992-3002</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18769626</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oncogene. 2008 Oct 6;27(45):5904-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18836471</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Pain Symptom Manage. 2009 Jan;37(1):107-28</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19111779</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Oncol. 2009 Jan;20(1):17-25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18678767</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Cancer. 2009 Feb;45(3):384-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18977131</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oncol Nurs Forum. 2009 Mar;36(2):209-16</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19273410</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Support Care Cancer. 2009 May;17(5):539-46</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18931862</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Palliat Support Care. 2009 Jun;7(2):213-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19538804</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Invest. 2000;18(4):293-302</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10808364</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</PubmedArticle>